Journey Medical Corp (DERM) Net margin 2020–2025
Journey Medical Corp (DERM) net profit margin by fiscal year — reported net income divided by reported revenue.
-18.7%FY2025 · since FY2020: 11.9% → -18.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -18.7% | +7.9 pp |
| FY2024 | -26.6% | -20.2 pp |
| FY2023 | -6.5% | +35.3 pp |
| FY2022 | -41.7% | +28.0 pp |
| FY2021 | -69.7% | -81.5 pp |
| FY2020 | 11.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DERM financial trends
DERM RevenueDERM Net incomeDERM Gross profitDERM Gross marginDERM Operating incomeDERM Operating marginDERM Operating cash flowDERM Free cash flowDERM Capital expendituresDERM Return on equityDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Total liabilitiesDERM Shareholders’ equityDERM overview →